STAAR Surgical Company (STAA): Price and Financial Metrics

STAAR Surgical Company (STAA): $49.79

1.81 (-3.51%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

B

STAA Price/Volume Stats

Current price $49.79 52-week high $73.13
Prev. close $51.60 52-week low $26.66
Day low $48.76 Volume 682,300
Day high $51.34 Avg. volume 783,720
50-day MA $36.27 Dividend yield N/A
200-day MA $39.09 Market Cap 2.43B

STAA Stock Price Chart Interactive Chart >


STAAR Surgical Company (STAA) Company Bio


STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.


STAA Latest News Stream


Event/Time News Detail
Loading, please wait...

STAA Latest Social Stream


Loading social stream, please wait...

View Full STAA Social Stream

Latest STAA News From Around the Web

Below are the latest news stories about STAAR SURGICAL CO that investors may wish to consider to help them evaluate STAA as an investment opportunity.

7 Stocks with Strong Insider Buying: December 2023

Stocks with strong insider buying should make you curious, and finding them can be a useful shortcut for your research

Chris Markoch on InvestorPlace | December 17, 2023

Lululemon Athletica gets one more downgrade ahead of Q3 report: 4 big analyst cuts

Unlock the potential of InvestingPro for up to 60% off this Cyber Monday Extended and never miss out on a market winner again.

Yahoo | December 5, 2023

Lilian Zhou Appointed to STAAR Surgical Board of Directors

LAKE FOREST, Calif., December 04, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Lilian Zhou to its Board of Directors, effective December 4, 2023.

Yahoo | December 4, 2023

Should Weakness in STAAR Surgical Company's (NASDAQ:STAA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

With its stock down 18% over the past month, it is easy to disregard STAAR Surgical (NASDAQ:STAA). However, the...

Yahoo | November 16, 2023

STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)

LAKE FOREST, Calif., November 15, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management will participate in the Stephens Annual Investment Conference on Thursday, November 16, 2023.

Yahoo | November 15, 2023

Read More 'STAA' Stories Here

STAA Price Returns

1-mo 32.00%
3-mo 65.58%
6-mo 16.91%
1-year -25.09%
3-year -57.88%
5-year 55.01%
YTD 59.53%
2023 -35.70%
2022 -46.83%
2021 15.25%
2020 125.25%
2019 10.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!